In MIT’s 2024 Killian Lecture, chemical engineer Paula Hammond described her groundbreaking work on nanoparticles designed to attack tumor cells.

Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.

The longtime academic leader of the Harvard-MIT Program in Health Sciences and Technology reflects on her time spent guiding students at the intersection of medicine and engineering.

The low-cost hardware outperforms state-of-the-art versions and could someday enable an affordable, in-home device for health monitoring.

MIT senior Daisy Wang interweaves biological engineering and women’s and gender studies as a way to address social problems.

MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.

MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.

This measure, developed by MIT researchers, reflects direct effects on people’s quality of life — and reveals significant global disparities.

Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.

Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.

Applied during endoscopic procedures, GastroShield could help prevent complications such as bleeding and leakage from weakened gastrointestinal tissues.

With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.

The technology could offer a cheap, fast way to test for PFAS, which have been linked to cancer and other health problems.

Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.

Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.

Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.

New MIT offering brings a multidisciplinary approach to tackling substance use disorder through biomedical device innovation.

MIT.nano Immersion Lab works with AR/VR startup to create transcontinental medical instruction.

A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.

Albert Almada PhD ’13 studies the mechanics of how stem cells rebuild tissues. “Digging deep into the science is what MIT taught me,” he says.

Over $1 million in prize funding available for tech-enabled solutions to the 2024 Global Challenges.

Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.

New PE.0539 course supports students who want to meet new people, strengthen friendships, build communities, and make MIT a more welcoming place.

MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.

MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.

Performing this test could help doctors prevent dysfunction that can occur when the right and left ventricles of the heart become imbalanced.

A longtime physician reflects on her journey from Thailand to MIT, and her four decades of service at MIT Health.

A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.

A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.

Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.

Dermatologists and general practitioners are somewhat less accurate in diagnosing disease in darker skin, a new study finds. Used correctly, AI may be able to help.

Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.

A new microscopy technique that enables high-resolution imaging could one day help doctors diagnose and treat brain tumors.

The MIT professor emerita and pioneering molecular biologist is being honored for her advocacy for women in science.

Faculty and researchers across MIT’s School of Engineering receive many awards in recognition of their scholarship, service, and overall excellence.

Twelve researchers selected as finalists for 2023-24 MIT-Royalty Pharma Prize Competition to support female entrepreneurs in biotech.

Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.

A compound originally developed to treat cancer could be repurposed to treat polycystic kidney disease, an inherited condition that can lead to kidney failure.

The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.

MIT CSAIL researchers develop advanced machine-learning models that outperform current methods in detecting pancreatic ductal adenocarcinoma.

The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.

Collaborative hub founded by philanthropist Lisa Yang will catalyze academic innovation and result in real-world, global impact.

Associate Professor Lydia Bourouiba and artist Argha Manna take readers through a series of discoveries in infectious disease.

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.

By reevaluating existing data, researchers find the procedure is even more valuable than consensus had indicated.

Cancer nanomedicine was on display at the 2023 White House Demo Day.

MIT professor combines nanoscience and viruses to develop solutions in energy, environment, and medicine.

Researchers are working to advance the field of glycoscience, illuminating the essential role of carbohydrates for human health and disease.

MIT and MGH researchers design a local, gel-based drug-delivery platform that may provoke a system-wide immune response to metastatic tumors.